Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katina Robison

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|April 21, 2016
Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancyBeth Cronin, Amy Bregar, Christine Luis, et al.
American Journal of Obstetrics and Gynecology|August 1, 2018
While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularityStephen Fiascone, Valery A Danilack, Mary J Kao, et al.
Gynecologic Oncology|March 18, 2014
Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy aloneKatina Robison, Dario Roque, Carolyn McCourt, et al.
Psycho-Oncology|October 23, 2015
Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary cancer programMelissa A Clark, Miles Ott, Michelle L Rogers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine LeiomyosarcomaDario R Roque, Kristin N Taylor, Marguerite Palisoul, et al.
Gynecologic Oncology|August 2, 2011
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell linesLaurent Brard, Thilo S Lange, Katina Robison, et al.
Gynecologic Oncology Reports|September 21, 2020
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgerySally Mullany, David Scott Miller, Katina Robison, et al.
Gynecologic Oncology Reports|June 9, 2025
The effect of intrawound vancomycin powder on surgical site infection in inguinal lymph node dissection: a randomized controlled trial pilot studyJessica B DiSilvestro, Emily Zitek, Katina Robison, et al.
Gynecologic Oncology|September 15, 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massElizabeth Lokich, Marguerite Palisoul, Nicole Romano, et al.
International Urogynecology Journal|August 14, 2024
Timing of Trial of Void After Radical Hysterectomy: Long-Term Urinary Outcomes at Two Academic Tertiary Care InstitutionsJulia K Shinnick, Alex Rosenthal, Jennifer Pearson, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|April 21, 2016
Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancyBeth Cronin, Amy Bregar, Christine Luis, et al.
American Journal of Obstetrics and Gynecology|August 1, 2018
While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularityStephen Fiascone, Valery A Danilack, Mary J Kao, et al.
Gynecologic Oncology|March 18, 2014
Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy aloneKatina Robison, Dario Roque, Carolyn McCourt, et al.
Psycho-Oncology|October 23, 2015
Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary cancer programMelissa A Clark, Miles Ott, Michelle L Rogers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine LeiomyosarcomaDario R Roque, Kristin N Taylor, Marguerite Palisoul, et al.
Gynecologic Oncology|August 2, 2011
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell linesLaurent Brard, Thilo S Lange, Katina Robison, et al.
Gynecologic Oncology Reports|September 21, 2020
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgerySally Mullany, David Scott Miller, Katina Robison, et al.
Gynecologic Oncology Reports|June 9, 2025
The effect of intrawound vancomycin powder on surgical site infection in inguinal lymph node dissection: a randomized controlled trial pilot studyJessica B DiSilvestro, Emily Zitek, Katina Robison, et al.
Gynecologic Oncology|September 15, 2015
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic massElizabeth Lokich, Marguerite Palisoul, Nicole Romano, et al.
International Urogynecology Journal|August 14, 2024
Timing of Trial of Void After Radical Hysterectomy: Long-Term Urinary Outcomes at Two Academic Tertiary Care InstitutionsJulia K Shinnick, Alex Rosenthal, Jennifer Pearson, et al.
Pageof 7